Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001104659-24-004901 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-18 | 2024-01-16 | PTGX | MOLINA ARTURO MD | Chief Medical Off | F - Tax | $24.63 | -427 | 48.4K | -0.9% | -$10.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-16 | F | D | 427 | $24.63 | 48,350 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,041 restricted stock units on January 15, 2024. |